Next-Generation Biologics: How Monoclonal Antibodies are Revolutionizing the Standard of Care in Modern Oncology
In the evolving landscape of precision medicine, antibodies have emerged as the most critical tool for combating chronic diseases. Unlike traditional chemotherapy, which affects both healthy and malignant cells, therapeutic antibodies can be engineered to recognize specific proteins on the surface of cancer cells. This specificity reduces toxicity and improves patient quality of life. The rise...
0 Commentarii 0 Distribuiri 964 Views 0 previzualizare